NOTE: All patients with greater than 10% abnormal CD4+ homogeneous CD3low strongly CD25+ expressing cells, or greater than 5% S(SqrRoot)(Copyright)zary cells, among the PBMCs in the peripheral blood will be deemed to have evaluable disease.